PDB Short entry for 1HEK HEADER VIRAL PROTEIN 24-NOV-00 1HEK TITLE CRYSTAL STRUCTURE OF EQUINE INFECTIOUS ANAEMIA VIRUS MATRIX ANTIGEN TITLE 2 (EIAV MA) COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAG POLYPROTEIN, CORE PROTEIN P15; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MA PROTEIN; COMPND 5 SYNONYM: EIAV MA, MATRIX PROTEIN, P15; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE PROTEIN HAS AN N-TERMINAL EXTENTION OF SEVEN COMPND 8 RESIDUES DUE TO THE EXPRESSION CONSTRUCT. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: EQUINE INFECTIOUS ANEMIA VIRUS; SOURCE 3 ORGANISM_COMMON: EIAV; SOURCE 4 ORGANISM_TAXID: 11665; SOURCE 5 STRAIN: ISOLATE WYOMING; SOURCE 6 VARIANT: CLONE P3.2-1; SOURCE 7 GENE: GAG; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PET-32A KEYWDS VIRAL PROTEIN, MEMBRANE-BINDING SWITCHING EXPDTA X-RAY DIFFRACTION AUTHOR H.HATANAKA,O.IOURIN,Z.RAO,E.FRY,A.KINGSMAN,D.I.STUART REVDAT 3 22-MAY-19 1HEK 1 REMARK LINK REVDAT 2 24-FEB-09 1HEK 1 VERSN REVDAT 1 23-NOV-01 1HEK 0 JRNL AUTH H.HATANAKA,O.IOURIN,Z.RAO,E.FRY,A.KINGSMAN,D.I.STUART JRNL TITL STRUCTURE OF EQUINE INFECTIOUS ANEMIA VIRUS MATRIX PROTEIN. JRNL REF J.VIROL. V. 76 1876 2002 JRNL REFN ISSN 0022-538X JRNL PMID 11799182 JRNL DOI 10.1128/JVI.76.4.1876-1883.2002 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 6153 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.279 REMARK 3 FREE R VALUE : 0.373 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.900 REMARK 3 FREE R VALUE TEST SET COUNT : 671 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.014 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 783 REMARK 3 BIN R VALUE (WORKING SET) : 0.4580 REMARK 3 BIN FREE R VALUE : 0.5870 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 12.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 115 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.055 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1844 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 79.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 22.08000 REMARK 3 B22 (A**2) : 22.08000 REMARK 3 B33 (A**2) : -44.15000 REMARK 3 B12 (A**2) : 24.47000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.56 REMARK 3 ESD FROM SIGMAA (A) : 0.88 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.70 REMARK 3 ESD FROM C-V SIGMAA (A) : 1.14 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.930 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.060 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.640 ; 4.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.810 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.500 ; 5.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.26 REMARK 3 BSOL : 50.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE C-TERMINAL RESIDUES 110 TO 124 WERE REMARK 3 NOT SEEN IN THE DENSITY MAPS REMARK 4 REMARK 4 1HEK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-NOV-00. REMARK 100 THE DEPOSITION ID IS D_1290005572. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9116, 0.9781, 0.9778 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6347 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 24.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.60000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: FIGURES ARE SHOWN FOR THE WAVELENGTH 0.91116. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG5000, 0.2M AMMONIUM SULFATE, REMARK 280 0.1M MES (PH6.5), 291K, PH 6.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 136.51333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 68.25667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 102.38500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 34.12833 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 170.64167 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 110 REMARK 465 LYS A 111 REMARK 465 THR A 112 REMARK 465 ALA A 113 REMARK 465 ASN A 114 REMARK 465 LYS A 115 REMARK 465 LYS A 116 REMARK 465 GLN A 117 REMARK 465 SER A 118 REMARK 465 GLU A 119 REMARK 465 PRO A 120 REMARK 465 SER A 121 REMARK 465 GLU A 122 REMARK 465 GLU A 123 REMARK 465 TYR A 124 REMARK 465 LYS B 110 REMARK 465 LYS B 111 REMARK 465 THR B 112 REMARK 465 ALA B 113 REMARK 465 ASN B 114 REMARK 465 LYS B 115 REMARK 465 LYS B 116 REMARK 465 GLN B 117 REMARK 465 SER B 118 REMARK 465 GLU B 119 REMARK 465 PRO B 120 REMARK 465 SER B 121 REMARK 465 GLU B 122 REMARK 465 GLU B 123 REMARK 465 TYR B 124 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 38 OG1 THR B 43 2.09 REMARK 500 O TRP A 79 N ALA A 81 2.13 REMARK 500 O GLY A 97 OG SER A 100 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MSE A -5 -168.05 -121.28 REMARK 500 ASP A -3 35.32 -78.43 REMARK 500 ILE A -2 -73.63 18.48 REMARK 500 SER A 0 -8.31 -141.50 REMARK 500 MSE A 1 11.80 30.06 REMARK 500 PRO A 4 -72.35 -44.41 REMARK 500 LEU A 11 -71.69 -49.61 REMARK 500 LYS A 12 -73.95 -32.77 REMARK 500 THR A 18 -173.36 -54.58 REMARK 500 GLN A 20 -116.53 -31.56 REMARK 500 SER A 22 44.71 -174.48 REMARK 500 LYS A 24 -171.05 -61.54 REMARK 500 CYS A 30 -71.81 -66.92 REMARK 500 ASN A 31 -27.01 -39.51 REMARK 500 THR A 43 -159.59 -84.61 REMARK 500 ASN A 44 34.78 -155.06 REMARK 500 TRP A 51 155.23 173.96 REMARK 500 LEU A 60 -70.12 -36.70 REMARK 500 GLU A 61 -49.97 -24.06 REMARK 500 GLN A 70 -30.01 -34.37 REMARK 500 GLU A 71 -37.27 -37.24 REMARK 500 ARG A 72 -74.30 -62.49 REMARK 500 TRP A 80 -49.53 -20.51 REMARK 500 ALA A 81 -84.70 -68.08 REMARK 500 MSE A 87 38.31 -84.36 REMARK 500 ASN A 93 155.93 172.94 REMARK 500 VAL A 94 -97.33 -60.67 REMARK 500 VAL A 95 -56.83 -13.54 REMARK 500 ASP A 96 98.39 -62.09 REMARK 500 ALA A 99 -78.35 -52.46 REMARK 500 SER A 100 -44.94 -24.90 REMARK 500 PHE A 101 -73.86 -58.30 REMARK 500 GLN A 102 -53.65 -26.80 REMARK 500 ARG A 105 -70.67 -75.95 REMARK 500 MSE B -5 -130.64 -87.65 REMARK 500 ASP B -3 122.89 161.15 REMARK 500 PRO B 4 -83.67 -49.37 REMARK 500 GLU B 15 -85.90 -46.31 REMARK 500 LYS B 16 -20.81 -20.66 REMARK 500 VAL B 19 -79.94 -113.15 REMARK 500 GLN B 20 -83.83 -84.25 REMARK 500 LEU B 34 5.17 -68.16 REMARK 500 LEU B 39 -72.07 -65.04 REMARK 500 PHE B 40 -78.63 -48.54 REMARK 500 ASP B 42 101.72 52.90 REMARK 500 THR B 43 -150.61 -156.17 REMARK 500 ASN B 44 -33.26 -143.16 REMARK 500 PHE B 45 -79.60 9.20 REMARK 500 LEU B 60 -36.41 -22.85 REMARK 500 LEU B 67 170.60 -53.51 REMARK 500 REMARK 500 THIS ENTRY HAS 64 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EIA RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF EQUINE INFECTIOUS ANEMIA VIRUS(EIAV) REMARK 900 CAPSID PROTEIN P26 REMARK 900 RELATED ID: 2EIA RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF EQUINE INFECTIOUS ANEMIA VIRUS(EIAV) REMARK 900 CAPSID PROTEIN P26 REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES -6 TO 0 ARE A CLONING ARTIFACT DBREF 1HEK A -6 0 PDB 1HEK 1HEK -6 0 DBREF 1HEK A 1 124 UNP P03351 GAG_EIAVY 1 124 DBREF 1HEK B -6 0 PDB 1HEK 1HEK -6 0 DBREF 1HEK B 1 124 UNP P03351 GAG_EIAVY 1 124 SEQADV 1HEK MSE A -5 PDB 1HEK MET -5 MODIFIED RESIDUE SEQADV 1HEK MSE A 1 UNP P03351 MET 1 MODIFIED RESIDUE SEQADV 1HEK MSE A 87 UNP P03351 MET 87 MODIFIED RESIDUE SEQADV 1HEK MSE B -5 PDB 1HEK MET -5 MODIFIED RESIDUE SEQADV 1HEK MSE B 1 UNP P03351 MET 1 MODIFIED RESIDUE SEQADV 1HEK MSE B 87 UNP P03351 MET 87 MODIFIED RESIDUE SEQRES 1 A 131 ALA MSE ALA ASP ILE GLY SER MSE GLY ASP PRO LEU THR SEQRES 2 A 131 TRP SER LYS ALA LEU LYS LYS LEU GLU LYS VAL THR VAL SEQRES 3 A 131 GLN GLY SER GLN LYS LEU THR THR GLY ASN CYS ASN TRP SEQRES 4 A 131 ALA LEU SER LEU VAL ASP LEU PHE HIS ASP THR ASN PHE SEQRES 5 A 131 VAL LYS GLU LYS ASP TRP GLN LEU ARG ASP VAL ILE PRO SEQRES 6 A 131 LEU LEU GLU ASP VAL THR GLN THR LEU SER GLY GLN GLU SEQRES 7 A 131 ARG GLU ALA PHE GLU ARG THR TRP TRP ALA ILE SER ALA SEQRES 8 A 131 VAL LYS MSE GLY LEU GLN ILE ASN ASN VAL VAL ASP GLY SEQRES 9 A 131 LYS ALA SER PHE GLN LEU LEU ARG ALA LYS TYR GLU LYS SEQRES 10 A 131 LYS THR ALA ASN LYS LYS GLN SER GLU PRO SER GLU GLU SEQRES 11 A 131 TYR SEQRES 1 B 131 ALA MSE ALA ASP ILE GLY SER MSE GLY ASP PRO LEU THR SEQRES 2 B 131 TRP SER LYS ALA LEU LYS LYS LEU GLU LYS VAL THR VAL SEQRES 3 B 131 GLN GLY SER GLN LYS LEU THR THR GLY ASN CYS ASN TRP SEQRES 4 B 131 ALA LEU SER LEU VAL ASP LEU PHE HIS ASP THR ASN PHE SEQRES 5 B 131 VAL LYS GLU LYS ASP TRP GLN LEU ARG ASP VAL ILE PRO SEQRES 6 B 131 LEU LEU GLU ASP VAL THR GLN THR LEU SER GLY GLN GLU SEQRES 7 B 131 ARG GLU ALA PHE GLU ARG THR TRP TRP ALA ILE SER ALA SEQRES 8 B 131 VAL LYS MSE GLY LEU GLN ILE ASN ASN VAL VAL ASP GLY SEQRES 9 B 131 LYS ALA SER PHE GLN LEU LEU ARG ALA LYS TYR GLU LYS SEQRES 10 B 131 LYS THR ALA ASN LYS LYS GLN SER GLU PRO SER GLU GLU SEQRES 11 B 131 TYR MODRES 1HEK MSE A -5 MET SELENOMETHIONINE MODRES 1HEK MSE A 1 MET SELENOMETHIONINE MODRES 1HEK MSE A 87 MET SELENOMETHIONINE MODRES 1HEK MSE B -5 MET SELENOMETHIONINE MODRES 1HEK MSE B 1 MET SELENOMETHIONINE MODRES 1HEK MSE B 87 MET SELENOMETHIONINE HET MSE A -5 8 HET MSE A 1 8 HET MSE A 87 8 HET MSE B -5 8 HET MSE B 1 8 HET MSE B 87 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 6(C5 H11 N O2 SE) HELIX 1 1 THR A 6 VAL A 17 1 12 HELIX 2 2 THR A 26 HIS A 41 1 16 HELIX 3 3 GLN A 52 GLN A 65 1 14 HELIX 4 4 GLN A 70 MSE A 87 1 18 HELIX 5 5 GLY A 97 GLU A 109 1 13 HELIX 6 6 THR B 6 GLU B 15 1 10 HELIX 7 7 THR B 26 HIS B 41 1 16 HELIX 8 8 ASN B 44 GLU B 48 5 5 HELIX 9 9 GLN B 52 GLN B 65 1 14 HELIX 10 10 GLY B 69 MSE B 87 1 19 HELIX 11 11 VAL B 94 ASP B 96 5 3 HELIX 12 12 GLY B 97 LYS B 107 1 11 LINK C ALA A -6 N MSE A -5 1555 1555 1.33 LINK C MSE A -5 N ALA A -4 1555 1555 1.33 LINK C SER A 0 N MSE A 1 1555 1555 1.34 LINK C MSE A 1 N GLY A 2 1555 1555 1.33 LINK C LYS A 86 N MSE A 87 1555 1555 1.33 LINK C MSE A 87 N GLY A 88 1555 1555 1.33 LINK C MSE B -5 N ALA B -4 1555 1555 1.33 LINK C ALA B -6 N MSE B -5 1555 1555 1.33 LINK C SER B 0 N MSE B 1 1555 1555 1.33 LINK C MSE B 1 N GLY B 2 1555 1555 1.33 LINK C LYS B 86 N MSE B 87 1555 1555 1.33 LINK C MSE B 87 N GLY B 88 1555 1555 1.34 CRYST1 47.150 47.150 204.770 90.00 90.00 120.00 P 65 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021209 0.012245 0.000000 0.00000 SCALE2 0.000000 0.024490 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004883 0.00000 MTRIX1 1 0.898050 -0.436290 0.056170 11.22631 1 MTRIX2 1 0.439150 0.896610 -0.056820 21.75827 1 MTRIX3 1 -0.025580 0.075700 0.996800 -18.20185 1